Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.

VANCOUVER, BC / ACCESS Newswire /4, 2026 / Kalo Gold Corp. (TSXV:KALO) (the "Company" or "Kalo") is pleased to announce the adoption of ...

A convincing fake Avast site displays a €499.99 charge and promises a refund. Instead, it harvests your name, address, and full credit card details.

Execution, integrity, and provenance determine PDF safety.

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced the publication of the analytical validation ...

In an era of seemingly infinite AI-generated content, the true differentiator for an organization will be data ownership and ...

Hargreave Hale AIM VCT has invested in LabGenius Therapeutics, a drug discovery company combining high-throughput experimentation and machine learning (ML) to ...

JFrog Ltd. (NASDAQ:FROG) Q4 2025 Earnings Call Transcript February 12, 2026 JFrog Ltd. beats earnings expectations. Reported EPS is $0.22, expectations were $0.19. Operator: Ladies and gentlemen, ...

WASHINGTON — A federal watchdog warned lawmakers that the Department of Veterans Affairs needs to fully revise the 80-year-old criteria for awarding disability payments or risk miscalculating benefits ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...